OnKure Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-18.5M | $-18.6M | $24.0K | $393.0K |
| FY2021 | $-38.0M | $-38.2M | $198.0K | $3.9M |
| FY2022 | $-47.4M | $-47.7M | $346.0K | $4.3M |
| FY2023 | $-34.5M | $-34.8M | $246.0K | $199.0K |
| FY2024 | $-51.1M | $-51.2M | $52.0K | $4.5M |
| FY2025 | $-51.8M | $-51.9M | $46.0K | $11.6M |